Fig. 2From: Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trialDistribution of the posterior mean of β based on 1000 simulated data sets for a given number of enrolments and odds ratios of a 1.00, b 0.95, c 0.87 and d 0.80Back to article page